MarketInOut Stock Screener Log In | Sign Up

Microba Life Sciences Ltd

Healthcare • Diagnostics & Research • Quote as of 10/28/2026 16:10
Microba Life Sciences Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
Market Capitalization25.21 mln
Float552 mln
Earnings Date03/03/2027

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.65
Highly reliable

1-Year Forecast

0.0822
Transformational upside

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.17
Very low leverage

Pre-Tax Margin

-142%
Severely loss-making

Business Description

Microba Life Sciences is an Australian health company founded in 2017 and headquartered in Brisbane, with customers across the United States, Europe, the United Kingdom, the Middle East, and Asia-Pacific. The company studies the bacteria and microorganisms living in the human gut and uses this knowledge to offer testing kits, supplements, and diagnostic tools for both individuals and researchers. Microba also applies its gut health data to develop new medical treatments targeting conditions such as inflammatory bowel disease and autoimmune disorders.

Key Fundamentals

EPS-0.03
ROE-71.41
RPS0.03
ROIC-61.94
ROA-47.60
Interest Cover-85.11
EBITDA, mln-16.33
EV / EBITDA-1.73
EV / EBIT-1.36
Revenue, mln14.76
EV / Revenue1.92

Quote Details

Last 0.035
Change 0 (0%)
Open 0.035
Volume 46,361
Turnover 1,622.64
Average Volume 262,707

Financial Ratios

Pre-Tax Profit Margin-142
Leverage Ratio1.63
Current Ratio1.24
Price / Book1.40
Debt / Equity0.17
Price / Sales2.04

Financial Strength

Altman Z-Score-3.49
Piotroski F-Score 4 / 9
Beneish M-Score-3.65
1-Year Target Price0.0822

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.5% 7 / 100   
1 Month -28.57% 7 / 100   
2 Months -16.67% 26 / 100   
6 Months -49.28% 11 / 100   
1 Year -57.83% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog